Finding 1228963 (2025-001)

Material Weakness Repeat Finding
Requirement
L
Questioned Costs
-
Year
2025
Accepted
2026-09-04
Audit: 410476
Organization: Overdose Lifeline, Inc. (IN)
Auditor: PILE CPAS

AI Summary

  • Core Issue: There is a significant weakness in the financial close process, leading to multiple material audit adjustments and inaccuracies in financial statements.
  • Impacted Requirements: The organization is failing to meet accounting principles generally accepted in the U.S., which affects the reliability of financial reporting and compliance with federal regulations.
  • Recommended Follow-Up: Review and improve the financial close process, focusing on reconciliations and general ledger reviews, with monthly or quarterly checks to ensure accuracy and compliance.

Finding Text

Finding 2025-001 Financial Close Process Type of Finding: Material Weakness in Internal Control over Financial Reporting Criteria: Management is responsible for adopting sound accounting policies and establishing and maintaining a system of internal control for the fair presentation of the basis financial statements in accordance with accounting principles generally accepted in the United States of America. Condition: The auditors noted a lack of a strong financial close process which led to multiple material audit adjustments that were proposed during the audit and recorded by the client to properly reflect various financial statement accounts. These adjustments also resulted in material changes to the total amount reported on the Consolidated Schedule of Expenditures of Federal Awards. Cause: Personnel responsible for the month-end close and financial statement reporting process lack the necessary skills, knowledge, and experience regarding the applicable requirements dictated under accounting principles generally accepted in the United States of America. Possible or Known Effect: The impact resulting from an inadequate financial close process has several profound effects. First, the deficiency compromises the reliability and integrity of financial statements, raising concerns about the accuracy of reported financial data and information. Second, the lack of an effective financial close process contributes to delays in the preparation and issuance of financial statements, impeding the organization's ability to provide financial statement users with timely information. Third, inaccurate financial reporting hinders effective resource allocation and budgeting, potentially leading to misguided financial decisions and mismanagement of funds. Finally, inadequate financial reporting processes could lead to non-compliance with federal reporting requirements and regulations. Questioned Costs: There were no questioned costs identified. Repeat Finding: This finding is a repeat from the prior year. The previous finding was 2024-001. Recommendation: We recommend that the Organization review their current financial statement close process paying special attention to all statement of financial position reconciliations and general ledger review of expense transactions. Considering the amount of activity on a monthly basis we recommend reconciling statement of financial position accounts on a monthly or quarterly basis. Views of Responsible Officials: The Organizations’ Board and Executive Team consisting of the Chief Executive Officer (“CEO”) and the Chief Operating Officer (“COO”) and key organizational personnel to include the independent bookkeeper and Grant and Finance Manager recognize the internal control deficiencies identified during the year 2025. We are reviewing the internal and contract staffing to understand gaps in audit compliance experience and will make the necessary adjustments.

Corrective Action Plan

Finding 2025-01 Financial Close Process Condition: The auditors noted lack of a strong financial close process which led to several material audit adjustments that were proposed during the audit and recorded by the client to properly reflect various financial statement accounts. These adjustments also resulted in material changes to the total amount reported on the Consolidated Schedule of Expenditures of Federal Awards. Corrective Actions Taken or Planned: The Organizations’ Board and Executive Team consisting of the Chief Executive Officer (CEO) and the Chief Operating Officer (COO) and key Overdose Lifeline (ODL) Staff to include the independent bookkeeper and Grant and Finance Manager recognize the internal control deficiencies identified during the year 2025. We are reviewing the internal and contract staffing to understand gaps in audit compliance experience and will make the necessary adjustments.

Categories

Reporting Allowable Costs / Cost Principles Material Weakness

Other Findings in this Audit

  • 1228954 2025-001
    Material Weakness Repeat
  • 1228955 2025-001
    Material Weakness Repeat
  • 1228956 2025-001
    Material Weakness Repeat
  • 1228957 2025-001
    Material Weakness Repeat
  • 1228958 2025-001
    Material Weakness Repeat
  • 1228959 2025-001
    Material Weakness Repeat
  • 1228960 2025-001
    Material Weakness Repeat
  • 1228961 2025-001
    Material Weakness Repeat
  • 1228962 2025-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
21.027 CORONAVIRUS STATE AND LOCAL FISCAL RECOVERY FUNDS $96,811
93.137 COMMUNITY PROGRAMS TO IMPROVE MINORITY HEALTH $41,215
16.540 JUVENILE JUSTICE AND DELINQUENCY PREVENTION $31,761
93.788 OPIOID STR $30,980
93.493 CONGRESSIONAL DIRECTIVES $22,404
16.838 COMPREHENSIVE OPIOID, STIMULANT, AND SUBSTANCE USE PROGRAM $684